• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE LTD. OPTUNE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE LTD. OPTUNE Back to Search Results
Model Number TFH-9000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fall (1848)
Event Date 09/01/2016
Event Type  Injury  
Manufacturer Narrative
Novocure agrees with the prescriber that the fall was related to optune therapy.Fall was reported as an adverse event in the ef-11 recurrent gbm pivotal trial (4% vs.0%, optune therapy vs.Chemotherapy; related 1% and 0% respectively).
 
Event Description
Patient is a (b)(6) male with recurrent glioblastoma who began optune therapy with concomitant bevacizumab on (b)(6) 2016.On september 1, 2016, spouse reported patient had experienced a fall while wearing the optune arrays.Patient was exercising at the time of the fall and the device was not plugged in.Cords of the arrays got caught on a weight rack and patient's head was pulled back hard enough to throw the patient to the ground.There was no loss of consciousness or seizure activity associated with the fall.Patient sustained a laceration on the corner of the head.Patient went to urgent care and received 14 staples.Patient was not hospitalized for the event.Physician advised patient to resume optune treatment in 2-3 days.Per the prescribing physician, the cause of the fall and injury was the optune array cords becoming entangled, causing the patient to trip and fall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTUNE
Type of Device
OPTUNE
Manufacturer (Section D)
NOVOCURE LTD.
topaz building, sha'ar
hacarmel 4th floor
haifa, is 31905
IS  31905
Manufacturer (Section G)
NOVOCURE LTD.
topaz building, sha'ar
hacarmel 4th floor
haifa, is 31905
IS   31905
Manufacturer Contact
eilon kirson
topaz building, sha'ar
hacarmel 4th floor
haifa, is 31905
IS   31905
48501204
MDR Report Key5997962
MDR Text Key56405173
Report Number3009453079-2016-00075
Device Sequence Number1
Product Code NZK
Combination Product (y/n)N
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient Family Member or Friend
Type of Report Initial
Report Date 10/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH-9000
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Device Age2 MO
Initial Date Manufacturer Received 09/15/2016
Initial Date FDA Received10/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/17/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BEVACIZUMAB; DEXAMETHASONE; LEVETIRACETAM; TEMOZOLOMIDE
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient Weight86
-
-